Introducing ISO 45001:2018 Auditor Training Certification Course Online to learn internal auditing skills and techniques to measure the effectiveness of Occupational, Health and Safety Management System
For other courses details visit: https://punyamacademy.com/
According to recent survey by Medicomp Systems, 43 percent of healthcare IT professionals and physicians cited that their top data-related challenge was not a lack of data but rather the struggle to access the right data at the right time. Those findings aren't surprising since the vast majority of health information systems today share a common design flaw: they don't think and work the way physicians do at the point of care. However, they are still deeply concerning.
To deliver the best patient care, physicians need clinically relevant data that is seamlessly presented within their current workflows and integrated into the same workspace. The result is not only better patient care and better outcomes but also higher clinical effectiveness, efficiency, and satisfaction.
To view the multimedia release go to:
https://www.multivu.com/players/English/8189651-medicomp-systems-ebook-healthcare-data-challenges/
Kohler raises the bar on toilet flushing platforms with the launch of its new Revolution 360 swirl flush technology. The brands extensive experience in the toilet industry supports its understanding that critical drivers of owner satisfaction are toilet cleanliness and flush performance – both addressed in the new platform.
Revolution 360 is Kohler’s most complete flush ever developed and is powered by the brand’s widely popular AquaPiston canister technology which allows water to flow out of the tank at 360 degrees, increasing the power and effectiveness of the flush. Once out of the tank the water flows into the bowl from a single, powerful port and swirls throughout the bowl. Utilizing this swirling motion, Revolution 360 keeps the bowl cleaner, longer than a conventional flush. Kohler’s team of engineers engaged experiment and Computational Fluid Dynamics methods to study, improve and perfect even the smallest details to ensure complete rinsing of the entire bowl surface.
To view the multimedia release go to:
https://www.multivu.com/players/English/8176751-kohler-revolution-360-toilet-flushing-platform/
Cornell University’s School of Hotel Administration and eCornell have launched new on-demand training in service excellence targeting front-line employees. The training consists of eight online lessons, all of which are available 24/7, and is complemented by a Workshop Guide to promote onsite, face-to-face discussion and application of the online lesson concepts. The training explores the foundations of service delivery and empowers employees through practical tools that can be applied to any situation involving internal or external customers.
Service Excellence On-Demand Training provides groups and organizations with a straightforward framework to increase effectiveness for all customer interactions. It provides employees with the skills needed to connect service excellence concepts to the execution of their daily duties, tasks, and responsibilities. Individuals who successfully complete all eight lessons will receive a recognition of their achievement from Cornell University’s School of Hotel Administration.
To view the multimedia release go to:
http://www.multivu.com/players/English/7975651-cornell-university-service-excellence-training/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
Sleep Inn, an all new construction brand and leader in the midscale lodging segment has revealed the latest evolution of its successful prototype. The concept builds upon the current prototype, which has demonstrated great appeal for its simply stylish aesthetic as well as its cost effectiveness to build and operate. The enhanced look and feel has evolved to meet the changing tastes and behaviors of travelers while still remaining cost neutral to today’s already efficient prototype. Leaders of the brand, which is franchised by Choice Hotels International, Inc. (NYSE: CHH), one of the world’s largest hotel companies, made the announcement during the Choice Hotels Annual Convention in Las Vegas attended by nearly 6,000 Choice Hotels franchisees and hospitality professionals.
To view the multimedia release go to:
http://www.multivu.com/players/English/7772451-choice-hotels-sleep-inn-prototype/
Every 33 seconds a child under 13 is involved in a car crash in the United States, according to 2014 data from the U.S. Department of Transportation’s National Highway Traffic Safety Administration (NHTSA). Safety seats, if used correctly, can dramatically reduce the risk of fatality or injury. But 59 percent of car seats are misused in a way that could reduce their effectiveness, and over one-third of children killed in car crashes were completely unrestrained at the time of the crash. Today, NHTSA and the Ad Council unveiled a new series of public service advertisements (PSAs) to educate parents and caregivers about the importance of selecting the right seat for their child’s age and size, and to remind them that car seats, booster seats and seat belts offer the best protection for children in crashes and help save lives.
“Life can change in an instant. We want parents and caregivers to prepare for the unexpected, rather than face their worst nightmare,” said Dr. Mark Rosekind, NHTSA administrator. “Buckling up a child correctly and in the right seat is the best protection any parent can do to see their child walk away unharmed from a car crash.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7774451-ad-council-find-the-right-seat/
Subaru of America, Inc. and Center for Pet Safety (CPS), a registered 501(c)(3) non-profit research and consumer advocacy organization, announced today the results of the 2015 Crate and Carrier Crashworthiness Studies - a collaborative initiative to examine the effectiveness and safety of pet crates and carriers in the event of a crash. After several eye-opening and informative tests - including instances of complete failure - three top products emerged; CPS has selected the Gunner Kennels G1 Intermediate with 8’ Tie Down Straps as the 2015 Top Performing Crate and both the PetEgo Forma Frame Jet Set Carrier with ISOFIX-Latch Connection and Sleepypod Mobile Pet Bed with PPRS Handilock as the 2015 Top Performing Carriers.
To view the multimedia news release, go to http://www.multivu.com/players/English/7074157-subaru-pet-safety/
Corporates today are on the lookout of new and novel ways to use their CSR funds effectively. A genuine step towards improving the quality of education in urban and especially rural areas would definitely interest them. And to make this possible, STEM Learning Pvt Ltd has launched Mini Science Centres (MSC) to promote experiential learning. STEM Learning is a pioneer in installing Mini Science Centres at schools in India. So far, they have installed over 40 Mega Science Centres and 250+ Mini Science Centres in Maharashtra, Gujarat, Chhattisgarh, Goa, Karnataka and Rajasthan. Their aim is to reach one million students from rural as well as urban areas of the country.
The Mini Science Project is an innovative concept developed by STEM Learning and consists of 60+ table-top models that are designed as per the syllabus of SSC, CBSC and ICSE Boards. These models come with a two-year warranty and maintenance. STEM learning also provides training to teachers to improve the effectiveness of these models in English and other vernacular languages.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7561751-stem-learning-mini-science-centre/
Se pone en marcha el primer estudio integral a largo plazo que compara diferentes medicaciones para el tratamiento de la diabetes tipo 2 a escala nacional. El estudio GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness - Estrategias para la reducción de la glucemia en la diabetes: una comparativa de la eficacia) comparará los efectos beneficiosos y riesgos a largo plazo de cuatro fármacos ampliamente utilizados en el tratamiento de la diabetes, en combinación con metformina, la medicación de primera línea más frecuente para tratar la diabetes tipo 2. El estudio GRADE está buscando voluntarios latinos.
Para ver el Multimedia News Release, vaya a http://www.multivu.com/mnr/65066-nih-grade-study-on-type-2-diabetes-medication-seeks-latino-volunteers
The first comprehensive long-term study comparing different medications for type 2 diabetes is launching nationwide. The GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study will compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64578-grade-glycemia-reduction-approaches-in-diabetes-comparative-effectiveness
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, today announced that it has acquired Ireland-based QUMAS, a leading global provider of Cloud-based and on-premises enterprise compliance software supporting regulatory and quality operations in life sciences and other highly regulated industries. The QUMAS acquisition further extends Accelrys’ informatics portfolio with the addition of mission-critical, end-to-end document and process management compliance solutions. Proven quality management solutions supported by robust content and business process management capabilities provided by QUMAS advance Accelrys’ ability to help customers better manage the scientific innovation lifecycle by reducing regulatory risks, lowering quality costs, improving compliance effectiveness and increasing operational efficiency in bringing new products to market.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62188-accelrys-acquires-compliance-and-quality-management-leader-qumas
